Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DCJ75Y
|
|||
| Drug Name |
CUTX-101
|
|||
| Synonyms |
Copper Histidine; Copper bis(histidinate); UNII-9078K3MO9U; 12561-67-0; 9078K3MO9U; Copper histidinate; Copper bishistidinate; Cu(His)2; L-Histidine, copper complex; Bishistidine copper(II) salt; Bis(L-histidinato-N,O)copper; SCHEMBL895831; DTXSID30154803; Copper, bis(L-histidinato-N,O)-; Copper, bis(L-histidinato-N,N3,O)-; L-Histidine, copper(2+) salt (2:1); Copper, bis(L-histidinato-kappaN,kappaO)-; 13870-80-9; Q27271298
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Menkes disease [ICD-11: 5C64.0; ICD-10: E83.0] | Phase 3 | [1] | |
| Company |
Cyprium Therapeutics
|
|||
| Structure |
 |
Download2D MOL
|
||
| Formula |
C12H16CuN6O4
|
|||
| Canonical SMILES |
C1=C(NC=N1)CC(C(=O)[O-])N.C1=C(NC=N1)CC(C(=O)[O-])N.[Cu+2]
|
|||
| InChI |
1S/2C6H9N3O2.Cu/c2*7-5(6(10)11)1-4-2-8-3-9-4;/h2*2-3,5H,1,7H2,(H,8,9)(H,10,11);/q;;+2/p-2/t2*5-;/m00./s1
|
|||
| InChIKey |
UUYDYUZBCIHUFZ-MDTVQASCSA-L
|
|||
| CAS Number |
CAS 12561-67-0
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of Cyprium Therapeutics. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.